M4MM
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Michigan Senate Tightens Controls on Intoxicating Hemp Derivatives
LANSING – In a bipartisan push to close regulatory gaps, the Michigan Senate approved a package of bills that would classify most high-potency hemp-derived THC items as Cannabis, folding them into the state's established Cannabis ...
Psilocybin Review Points to Rapid Relief for Treatment-Resistant Depression
LOS ANGELES – A new systematic review of clinical studies underscores psilocybin's potential to deliver quick and lasting reductions in depressive symptoms, offering a targeted option for patients who see little benefit from standard medications. ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
OPINION: The People Have Spoken: It’s Time to End Federal Cannabis Prohibition (and Release the Epstein Files)
LOS ANGELES- With 87% of Americans supporting Cannabis legalization — and nearly 80% demanding the release of the Epstein files — public consensus on reform and transparency has never been stronger. The question now is ...
Texas Awards $50M Grant to Spearhead Ibogaine Trials
AUSTIN – The Texas Health and Human Services Commission has granted $50 million to a statewide consortium led by UTHealth Houston and the University of Texas Medical Branch at Galveston, marking the formal launch of ...
Vireo Growth Acquires PharmaCann Colorado Assets
DENVER – Vireo Growth Inc. reached an agreement with PharmaCann Inc. to buy its 17 operational dispensaries and related assets in Colorado for roughly $49 million in company shares, a move that bolsters Vireo's retail ...
Michigan Senate Tightens Controls on Intoxicating Hemp Derivatives
LANSING – In a bipartisan push to close regulatory gaps, the Michigan Senate approved a package of bills that would classify most high-potency hemp-derived THC items as Cannabis, folding them into the state's established Cannabis ...
Ohio Governor Urges Ban on Intoxicating Hemp Products Targeting Youth
NEW YORK– In a decisive call to action, Ohio Governor Mike DeWine urged state lawmakers to ban "intoxicating hemp" products, including all delta-8 THC goods, amid concerns over their appeal to minors. This appeal comes ...
FDA Endorses Historic Shift in Cannabis Classification to Schedule III
LOS ANGELES- In a landmark development, the U.S. Food and Drug Administration (FDA) has advocated for a significant reclassification of cannabis under the Controlled Substances Act (CSA). The agency proposed that cannabis be moved from ...
Exploring Cannabinoids in the Battle Against COVID-19: A Comprehensive Review
LOS ANGELES- In the ongoing quest to understand and combat COVID-19, a recent study titled “Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19,” presents intriguing possibilities offered by cannabinoids. Authored by ...
Filament Health Achieves Milestone with First Botanical Psilocybin Export to Australia
NEW YORK – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS), a trailblazer in the realm of natural psychedelic drug development, announced a significant milestone in its global expansion with the successful export of ...
DEA Proposes Increased Production Quotas for Cannabis and Psychedelics
LOS ANGELES- In a significant policy shift, the Drug Enforcement Administration (DEA) has proposed substantial increases in the production quotas for cannabis and various psychedelics for 2024. This move reflects a growing recognition of the ...
Numinus Wellness Inc. Announces First Quarter Fiscal 2024
NEW YORK – Numinus Wellness Inc. a mental health care emphasizing psychedelic-assisted therapies, has released its financial figures for the first quarter of fiscal year 2024, ending November 30, 2023. The results reveal a nuanced ...
Rhode Island Explores Psilocybin Reform with a New Legislative Proposal
NEW TORK- In a significant legislative move, Rhode Island Representative Brandon Potter (D) has introduced a bill aimed at reforming the state's approach to psilocybin, the active compound in "magic mushrooms." The bill, H 7047, ...
Michigan’s Cannabis Industry Soars, Surpassing the GDP of 51 Nations in 2023
LOS ANGELES— Michigan's cannabis industry closed 2023 on a high, establishing itself as a national leader in cannabis sales. The state's robust cannabis market sold nearly $3.06 billion worth of medical and adult-use cannabis last ...
Canadian Cannabis Market Updates: A New Regulatory Shift in Ontario’s Cannabis Retail Landscape
TORONTO- Announced on November 30 and implemented on January 1, Ontario's cannabis market witnessed a significant policy change, allowing one company to operate up to 150 recreational cannabis stores—a notable increase from the previous cap ...
Pentagon Responds to Rising Overdose Deaths with New Drug Policy Initiatives
LOS ANGELES- In an unprecedented move, the Department of Defense is set to implement a new policy in 2024 to address the escalating issue of drug overdoses within the United States military. This initiative, prompted ...
Federal Scientists Advocate for Reclassifying Cannabis to Schedule III
LOS ANGELES-In a significant shift in federal policy, scientists from the Health and Human Services (HHS) have recommended reclassifying cannabis from a Schedule I to a Schedule III substance, as revealed in recently unredacted documents. ...
Exploring Cannabinoids as a Potential Treatment Avenue for COVID-19 and Long-COVID
LOS ANGELES- In a groundbreaking development in the ongoing battle against COVID-19, a team of Canadian researchers has presented a comprehensive review that suggests a potential therapeutic role for cannabinoids. The study, entitled “Cannabinoids and ...
Belgium’s Drug Policy Reform: A Deliberate Move Toward Decriminalization Inspired by Portugal’s Model
BRUSSELS- Belgium is currently considering significant reforms in its drug policy, a move inspired by Portugal’s successful decriminalization model. Ine Van Wymersch, Belgium’s National Drug Commissioner and a former prosecutor, is advocating for the decriminalization of ...
California Cannabis Regulators Issue Health-Related Recalls on Products
LOS ANGELES- In a statement released on Wednesday, the DCC outlined the details of two separate recalls involving cannabis products. The recalls underscore ongoing regulatory vigilance in the burgeoning cannabis industry, particularly in California, a ...
New York Cannabis Control Board Approves Two More Operators for Recreational Market
NEW YORK — In a remarkably swift meeting on Friday, the New York Cannabis Control Board (CCB) made a significant decision, approving the transition of two additional multi-state operators (MSOs) from the medical to the ...
